Skip to Content

ZE68 (Glipizide and metformin hydrochloride 2.5 mg / 250 mg)

Pill imprint ZE68 has been identified as Glipizide and metformin hydrochloride 2.5 mg / 250 mg.

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Glipizide and metformin hydrochloride
Imprint:
ZE68
Strength:
2.5 mg / 250 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Cadila Healthcare Limited

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide